The WHO Global Diabetes Compact: a new initiative to support people living with diabetes [0.03%]
世卫组织全球糖尿病公约：一项支持糖尿病患者的新倡议
Daniel Hunt,Bianca Hemmingsen,Alena Matzke et al.
Daniel Hunt et al.
Jane Elizabeth Hirst,Charlotte Frise,Gaya Thanabalasingham et al.
Jane Elizabeth Hirst et al.
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes? [0.03%]
新冠肺炎会引起糖尿病吗？警惕高血糖中的“李鬼”与“李逵”
Mark A Atkinson,Alvin C Powers
Mark A Atkinson
Paul Lips
Paul Lips
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial [0.03%]
volanesorsen治疗多因素乳糜微粒血症患者的有效性和安全性（COMPASS）：一项多中心、双盲、随机、安慰剂对照的三期试验
Ioanna Gouni-Berthold,Veronica J Alexander,Qingqing Yang et al.
Ioanna Gouni-Berthold et al.
Background: Volanesorsen is an antisense oligonucleotide that targets hepatic apolipoprotein C-III synthesis and reduces plasma triglyceride concentration. The aim of this study was to explore the safety and efficacy of v...
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials [0.03%]
维生素D补充剂预防呼吸道感染的系统评价和荟萃分析
David A Jolliffe,Carlos A Camargo Jr,John D Sluyter et al.
David A Jolliffe et al.
Background: A 2017 meta-analysis of data from 25 randomised controlled trials (RCTs) of vitamin D supplementation for the prevention of acute respiratory infections (ARIs) revealed a protective effect of this intervention...
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England [0.03%]
英国全国范围内的观察性研究：2 型糖尿病患者降糖药物的处方与新冠肺炎死亡率的关系
Kamlesh Khunti,Peter Knighton,Francesco Zaccardi et al.
Kamlesh Khunti et al.
Background: In patients with type 2 diabetes, hyperglycaemia is an independent risk factor for COVID-19-related mortality. Associations between pre-infection prescription for glucose-lowering drugs and COVID-19-related mo...
Observational Study
The lancet. Diabetes & endocrinology. 2021 May;9(5):293-303. DOI:10.1016/S2213-8587(21)00050-4 2021
Gerald F Watts,Natalie C Ward
Gerald F Watts
Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? [0.03%]
降糖药物会影响2型糖尿病患者新冠肺炎预后吗？
Guntram Schernthaner
Guntram Schernthaner